JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NWLI
4351
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $467K | ﹤0.01% |
1,661
+128
| +8% | +$27.3K |
2016 Q4
24 quarters
|
|
4352
Bain Capital Specialty
BCSF
$702M
| $466K | ﹤0.01% |
39,170
+1,068
| +3% | +$13.6K |
2019 Q2
14 quarters
|
|
4353
Ituran Location and Control
ITRN
$1.03B
| $466K | ﹤0.01% |
22,078
-10,867
| -33% | -$248K |
2016 Q1
27 quarters
|
|
4354
Novavax
NVAX
$1.87B
| $465K | ﹤0.01% |
45,272
-6,718
| -13% | -$119K |
2014 Q3
33 quarters
|
|
|
BHIL
4355
DELISTED
Benson Hill, Inc.
BHIL
| $465K | ﹤0.01% |
5,210
+1,159
| +29% | +$113K |
2021 Q3
5 quarters
|
|
4356
ARK Genomic Revolution ETF
ARKG
$2.12B
| $464K | ﹤0.01% |
16,435
-1,452
| -8% | -$46.1K |
2019 Q4
12 quarters
|
|
|
JAMF
4357
DELISTED
Jamf
JAMF
| $463K | ﹤0.01% |
21,743
-533
| -2% | -$11.7K |
2020 Q3
9 quarters
|
|
4358
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$7.16B
| $463K | ﹤0.01% |
16,042
| – | – |
2021 Q3
5 quarters
|
|
4359
CALL
Humana
HUM
$48.5B
| $461K | ﹤0.01% |
900
| – | – |
2021 Q2
6 quarters
|
|
4360
Invesco Financial Preferred ETF
PGF
$605M
| $460K | ﹤0.01% |
31,915
-6,306
| -16% | -$93.3K |
2014 Q1
35 quarters
|
|
4361
HighPeak Energy
HPK
$1.04B
| $459K | ﹤0.01% |
20,112
+10,084
| +101% | +$227K |
2021 Q1
7 quarters
|
|
|
VRN
4362
DELISTED
Veren
VRN
| $455K | ﹤0.01% |
63,579
-261,534
| -80% | -$1.94M |
2014 Q1
35 quarters
|
|
4363
Cerus
CERS
$472M
| $454K | ﹤0.01% |
124,695
-11,638
| -9% | -$43.9K |
2017 Q1
23 quarters
|
|
4364
Omega Flex
OFLX
$266M
| $454K | ﹤0.01% |
4,859
+1,067
| +28% | +$101K |
2017 Q4
20 quarters
|
|
4365
Citi Trends
CTRN
$410M
| $452K | ﹤0.01% |
17,083
-217,092
| -93% | -$5.11M |
2016 Q2
26 quarters
|
|
4366
Invesco KBW High Dividend Yield Financial ETF
KBWD
$357M
| $452K | ﹤0.01% |
30,431
-183
| -0.6% | -$2.8K |
2020 Q1
11 quarters
|
|
|
APCA
4367
DELISTED
AP Acquisition Corp
APCA
| $452K | ﹤0.01% |
43,800
| – | – |
2022 Q1
3 quarters
|
|
|
ARCE
4368
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $452K | ﹤0.01% |
33,453
-445,489
| -93% | -$4.99M |
2020 Q4
8 quarters
|
|
4369
WisdomTree International Quality Dividend Growth Fund
IQDG
$688M
| $450K | ﹤0.01% |
14,713
+14,471
| +5,980% | +$425K |
2022 Q3
1 quarter
|
|
4370
CALL
Tractor Supply
TSCO
$16.8B
| $450K | ﹤0.01% |
+10,000
| New | +$425K |
2022 Q4
0 quarters
|
|
4371
Direxion Daily GOOGL Bull 2X ETF
GGLL
$1.1B
| $449K | ﹤0.01% |
25,000
| – | – |
2022 Q3
1 quarter
|
|
|
SRDX
4372
DELISTED
Surmodics
SRDX
| $449K | ﹤0.01% |
13,123
+954
| +8% | +$32K |
2013 Q2
38 quarters
|
|
4373
Codexis
CDXS
$149M
| $448K | ﹤0.01% |
96,095
+37,157
| +63% | +$204K |
2017 Q3
21 quarters
|
|
|
HAIA
4374
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
| $446K | ﹤0.01% |
43,600
| – | – |
2022 Q1
3 quarters
|
|
4375
PUT
Illumina
ILMN
$41.3B
| $445K | ﹤0.01% |
+2,262
| New | +$469K |
2022 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.